Stock Track | BEIGENE Plummets 7.45% in Pre-market on Earnings Caution and Below-Guide Revenue Outlook

Stock Track02-26

BEIGENE LTD's American depositary shares experienced a significant pre-market plummet of 7.45% on Thursday, reflecting heavy selling pressure at the market open.

The sharp decline comes as the innovative drug company is scheduled to release its 2025 financial report, with investors exhibiting caution and negative expectations ahead of the earnings announcement. Market sentiment was further dampened by the company's 2026 revenue guidance, which fell below analyst estimates, contributing to the sell-off.

The stock's drop also reflected broader weakness in the pharmaceutical sector, where innovative drug stocks led market declines during the session. As a leading component of several pharmaceutical ETFs, BEIGENE's performance is closely watched by investors tracking the healthcare industry's transition from research and development to commercialization.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1181796814?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-26 23:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181796814","market":"us","top_or_hot":-1,"title":"Stock Track | BEIGENE Plummets 7.45% in Pre-market on Earnings Caution and Below-Guide Revenue Outlook","media":"Stock Track","content":"<p>BEIGENE LTD's American depositary shares experienced a significant pre-market plummet of 7.45% on Thursday, reflecting heavy selling pressure at the market open.</p><p>The sharp decline comes as the innovative drug company is scheduled to release its 2025 financial report, with investors exhibiting caution and negative expectations ahead of the earnings announcement. Market sentiment was further dampened by the company's 2026 revenue guidance, which fell below analyst estimates, contributing to the sell-off.</p><p>The stock's drop also reflected broader weakness in the pharmaceutical sector, where innovative drug stocks led market declines during the session. As a leading component of several pharmaceutical ETFs, BEIGENE's performance is closely watched by investors tracking the healthcare industry's transition from research and development to commercialization.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | BEIGENE Plummets 7.45% in Pre-market on Earnings Caution and Below-Guide Revenue Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | BEIGENE Plummets 7.45% in Pre-market on Earnings Caution and Below-Guide Revenue Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-26 23:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIGENE LTD's American depositary shares experienced a significant pre-market plummet of 7.45% on Thursday, reflecting heavy selling pressure at the market open.</p><p>The sharp decline comes as the innovative drug company is scheduled to release its 2025 financial report, with investors exhibiting caution and negative expectations ahead of the earnings announcement. Market sentiment was further dampened by the company's 2026 revenue guidance, which fell below analyst estimates, contributing to the sell-off.</p><p>The stock's drop also reflected broader weakness in the pharmaceutical sector, where innovative drug stocks led market declines during the session. As a leading component of several pharmaceutical ETFs, BEIGENE's performance is closely watched by investors tracking the healthcare industry's transition from research and development to commercialization.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ONC","symbol_name":"百济神州","start_time":0,"source_url":"","article_id":"1181796814","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181796814","pubTimestamp":1772119992,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"BEIGENE LTD's American depositary shares experienced a significant pre-market plummet of 7.45% on Thursday, reflecting heavy selling pressure at the market open.The sharp decline comes as the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ONC":"百济神州"},"translate_title":"个股追踪|百济神州盘前暴跌7.45%因财报谨慎及营收前景低于指引","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ONC":1},"content_text":"BEIGENE LTD's American depositary shares experienced a significant pre-market plummet of 7.45% on Thursday, reflecting heavy selling pressure at the market open.The sharp decline comes as the innovative drug company is scheduled to release its 2025 financial report, with investors exhibiting caution and negative expectations ahead of the earnings announcement. Market sentiment was further dampened by the company's 2026 revenue guidance, which fell below analyst estimates, contributing to the sell-off.The stock's drop also reflected broader weakness in the pharmaceutical sector, where innovative drug stocks led market declines during the session. As a leading component of several pharmaceutical ETFs, BEIGENE's performance is closely watched by investors tracking the healthcare industry's transition from research and development to commercialization.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1181796814","isCrawlerRequest":true}